ADVFN - Advanced Financial Network.
HOME» NASDAQ » H » HGSI Stock Price » HGSI Stock News

Human Genome Sciences Share News

 Human Genome Sciences (mm) Stock Price
HGSI Stock Price
 Human Genome Sciences (mm) Stock Chart
HGSI Stock Chart
 Human Genome Sciences (mm) Stock News
HGSI Stock News
 Human Genome Sciences (mm) Company Information
HGSI Company Information
 Human Genome Sciences (mm) Stock Trades
HGSI Stock Trades

GSK Gets Renewed Invitation to Human Genome Sciences Strategic Review

LONDON--Pharmaceutical company GlaxoSmithKline PLC (GSK.LN) Friday confirmed that it has received a renewed invitation from Human Genome Sciences (HGSI) to participate in its strategic alternatives review process which started in April, and said it is continuing with its tender for the company. MAIN FACTS: -GSK continues to believe that participation in the process is unnecessary given the company's offer is not conditioned on due diligence or financing and can be completed expeditiously. -Shares at 1405 GMT down 0.7%, at 1,449 pence valuing the company at GBP72.6 billion. -Write to Ed Ballard at

Stock News for Human Genome Sciences (HGSI)
No Recent News Available

Human Genome Sciences and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations